Search Results - "MOK, Tony Shu Kam"

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study by Chan, Stephen Lam, Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Yuen, Becky Wing‐Yan, Luk, Hester Wing‐Sum, Lui, Rashid Nok‐Shun, Chan, Henry Lik‐Yuen, Mok, Tony Shu‐Kam, Wong, Grace Lai‐Hung

“…Background Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of cancers. We aimed to evaluate the incidence and prognostic impact of…”
Get full text

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers by Wong, Vincent Wai-Sun, Chan, Stephen Lam, Mo, Frankie, Chan, Tung-Ching, Loong, Herbert Ho-Fung, Wong, Grace Lai-Hung, Lui, Yanni Yan-Ni, Chan, Anthony Tak-Cheung, Sung, Joseph Jao-Yiu, Yeo, Winnie, Chan, Henry Lik-Yuen, Mok, Tony Shu-Kam

“…Hepatitis B virus (HBV) infection is an important etiology for hepatocellular carcinoma (HCC). We aim to develop a simple clinical score in predicting the risk…”
Get full text

High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma by CHAN, Henry Lik-Yuen, TSE, Chi-Hang, MO, Frankie, KOH, Jane, WONG, Vincent Wai-Sun, WONG, Grace Lai-Hung, CHAN, Stephen Lam, YEO, Winnie, SUNG, Joseph Jao-Yiu, MOK, Tony Shu-Kam

“…We aimed to investigate the impact of hepatitis B virus (HBV) DNA and HBV genotypes/subgenotypes on the risk of hepatocellular carcinoma (HCC). A prospective…”
Get full text

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer by Loong, Herbert H., Kwan, Sui-chun Sampson, Mok, Tony Shu-kam, Lau, Yat-ming

“…Opinion statement Non-small cell lung cancer (NSCLC) harboring epidermal growth receptor (EGFR) mutation has distinct genomic characteristics. Introduction of…”
Get full text

Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma by Wu, Claudia Wing-Kwan, Lui, Rashid Nok-Shun, Wong, Vincent Wai-Sun, Yam, Tsz-Fai, Yip, Terry Cheuk-Fung, Liu, Ken, Lai, Jimmy Che-To, Tse, Yee-Kit, Mok, Tony Shu-Kam, Chan, Henry Lik-Yuen, Ng, Kelvin Kwok-Chai, Wong, Grace Lai-Hung, Chan, Stephen Lam

“…The Baveno VII criteria are used in patients with liver cirrhosis to predict high-risk varices in patients with liver cirrhosis. Yet its use in patients with…”
Get full text

Distinct Molecular Landscape of Epstein–Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing by Chau, Shuk-Ling, Tong, Joanna Hung-Man, Chow, Chit, Kwan, Johnny Sheung-Him, Lung, Raymond Wai-Ming, Chung, Lau-Ying, Tin, Edith Ka-Yee, Wong, Shela Shu-Yan, Cheung, Alvin Ho-Kwan, Lau, Rainbow Wing-Hung, Ng, Calvin Sze-Hang, Mok, Tony Shu-Kam, Lo, Kwok-Wai, To, Ka-Fai

“…Pulmonary lymphoepithelioma-like carcinoma (LELC) is a subtype of non-small cell lung cancer (NSCLC) characterized by marked lymphocytic infiltration and…”
Get full text

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 by Yang, James C-H, Prof, Sequist, Lecia V, MD, Geater, Sarayut Lucien, MD, Tsai, Chun-Ming, Prof, Mok, Tony Shu Kam, Prof, Schuler, Martin, Prof, Yamamoto, Nobuyuki, Prof, Yu, Chong-Jen, Prof, Ou, Sai-Hong I, MD, Zhou, Caicun, Prof, Massey, Daniel, MSc, Zazulina, Victoria, MD, Wu, Yi-Long, Prof

“…Summary Background Most patients with non-small-cell lung cancer tumours that have EGFR mutations have deletion mutations in exon 19 or the Leu858Arg point…”
Get full text

Symposium: "Oncology Leadership in Asia" by Noh, Dong-Young, Roh, Jae Kyung, Kim, Yeul Hong, Yoshida, Kazuhiro, Baba, Hideo, Samson-Fernando, Marie Cherry Lynn, Misra, Sanjeev, Aziz, Zeba, Umbas, Rainy, P Singh, Yogendra, Shu Kam Mok, Tony, Yang, Han-Kwang, Akaza, Hideyuki

“…The symposium on "Oncology Leadership in Asia" was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with…”
Get full text

A Memetic Algorithm for Multiple-Drug Cancer Chemotherapy Schedule Optimization by Tse, S.-M., Yong Liang, Kwong-Sak Leung, Kin-Hong Lee, Mok, T.S.-K.

“…This correspondence introduces a multidrug cancer chemotherapy model to simulate the possible response of the tumor cells under drug administration. We…”
Get full text

Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection by Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Tse, Yee-Kit, Liang, Lilian Yan, Lui, Rashid Nok-Shun, Mok, Tony Shu-Kam, Chan, Henry Lik-Yuen, Chan, Stephen Lam

“…Immunotherapy has dramatically improved the survival of patients with advanced or metastatic malignancies. Recent studies suggest that immunotherapy may…”
Get full text

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma by Poon, T C, Chan, A T, Zee, B, Ho, S K, Mok, T S, Leung, T W, Johnson, P J

“…Although many attempts have been made to identify tumour-specific alpha-fetoprotein (AFP) glycoforms or other serological markers for the diagnosis of…”
Get more information

Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages by Wu, Claudia Wing‐Kwan, Wong, Grace Lai‐Hung, Wong, Vincent Wai‐Sun, Yam, Tsz‐Fai, Yip, Terry Cheuk‐Fung, Wong, Angus Chun‐Hei, Chan, Brian Wai‐Nok, Fong, Matthew Man‐Lok, Lai, Jimmy Che‐To, Tse, Yee‐Kit, Lee, Kit‐Fai, Mok, Tony Shu‐Kam, Chan, Henry Lik‐Yuen, Lui, Rashid Nok‐Shun, Chan, Stephen Lam, Ng, Kelvin Kwok‐Chai

“…Background Baveno VII criteria for predicting varices needing treatment (VNT) have not been tested in hepatocellular carcinoma (HCC) population. We evaluated…”
Get full text

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations by Ahn, Myung-Ju, Mendoza, Marvin Jonne L., Pavlakis, Nick, Kato, Terufumi, Soo, Ross A., Kim, Dong-Wan, Liam, Chong Kin, Hsia, Te-Chun, Lee, Chee Khoon, Reungwetwattana, Thanyanan, Geater, Sarayut, Chan, Oscar Siu Hong, Prasongsook, Naiyarat, Solomon, Benjamin J., Nguyen, Thi Thai Hoa, Kozuki, Toshiyuki, Yang, James Chih-Hsin, Wu, Yi-Long, Mok, Tony Shu Kam, Tan, Daniel Shao-Weng, Yatabe, Yasushi

“…•MET alterations are associated with tumorigenesis and TKI resistance in patients with non-small cell lung cancer (NSCLC)•ATORG provides recommendations for…”
Get full text

Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells by Lui, Vivian Wai Yan, Lau, Cecilia Pik Yuk, Ho, KaKiu, Ng, Margaret Heung Ling, Cheng, Suk Hang, Tsao, Sai-Wah, Tsang, Chi Man, Lei, Kenny Ieng Kit, Chan, Anthony TC, Mok, Tony Shu Kam

“…Summary Nasopharyngeal cancer (NPC) is a highly prevalent and invasive head and neck cancer in Asia. Disease recurrence and distant metastasis account for…”
Get full text

A Comparison of Three Transarterial Lipiodol-Based Formulations for Hepatocellular Carcinoma: In Vivo Biodistribution Study in Humans by Yu, Simon Chun Ho, Leung, Thomas Wai Tong, Lau, Wan Yee, Lee, Nelson, Hui, Edwin Pun, Yeo, Winnie, Lai, Paul Bo San, Mok, Tony Shu Kam

“…This study aimed to evaluate and compare the biodistribution properties of three transarterial Lipiodol-based therapeutic regimens in human hepatocellular…”
Get full text

Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection by Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Tse, Yee-Kit, Liang, Lilian Yan, Lui, Rashid Nok-Shun, Mok, Tony Shu-Kam, Chan, Henry Lik-Yuen, Chan, Stephen Lam

Get full text

A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma by Mok, Tony Shu Kam, Geater, Sarayut Lucien, Su, Wu-Chou, Tan, Eng-Huat, Yang, James Chi-Hsin, Chang, Gee-Chen, Han, May, Komarnitsky, Philip, Payumo, Francis, Garrus, Jennifer E, Close, Sandra, Park, Keunchil

“…A randomized phase 2 study was designed to compare the combination of ficlatuzumab (AV-299), a humanized hepatocyte growth factor-neutralizing monoclonal…”
Get more information

Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI by Cheong, Hio Teng, Xu, Fei, Choy, Chi Tung, Hui, Connie Wun Chun, Mok, Tony Shu Kam, Wong, Chi Hang

“…Lung cancer has the highest incidence and mortality rate worldwide among all malignancy-associated mortalities, of which non-small cell lung cancer accounts…”
Get full text

Abstract 2558: The mechanistic study on the effect of platinum-based chemotherapy efficacy imposed by EGFR-TKI regulated ERCC1 in non-small cell lung cancer (NSCLC) by Cheong, Hio Teng, Hui, Connie Wun Chun, Xu, Fei, Mok, Tony Shu Kam, Wong, Chi Hang

“…Abstract Platinum-based chemotherapy is conventionally the first line treatment for EGFR wild type patients while EGFR-TKI is the standard for patients with…”
Get full text

Multi-drug cancer chemotherapy scheduling by a new memetic optimization algorithm by Sui-Man Tse, Yong Liang, Kwong-Sak Leung, Kin-Hong Lee, Shu-Kam Tony Mok

“…This paper proposes a new memetic algorithm (MA) to solve the multi-drug chemotherapy optimization problem. The new MA combines GA with a local search…”
Get full text